Published in Virus Weekly, April 10th, 2007
Currently, Dr. Hong is Executive Vice President and Chief Scientific Officer of Ardea Biosciences, Inc., a San Diego, California, biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to treat viral diseases, cancer, and inflammation. He earlier served as Vice President and Head of Research at Valeant Pharmaceuticals International, where he built up the Discovery group to eventually lead the entire Research group of approximately 120 staff to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.